Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy D Henry

Showing results (461-470 of 573) with videos related to

Pageof 58
Sort By:
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
Pageof 58

Showing results (461-470 of 573) with videos related to

Sort By:
Pageof 58
American Heart Journal|March 11, 2025
Rationale and design of the ILIAS ANOCA clinical trial: A blinded-arm controlled trial for routine ad-hoc coronary function testingCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Circulation. Cardiovascular Interventions|June 10, 2015
Prevalence and impact of high platelet reactivity in chronic kidney disease: results from the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents registryUsman Baber, Roxana Mehran, Ajay J Kirtane, et al.
JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.
American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.
Journal of the American College of Cardiology|August 29, 2015
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary InterventionPhilippe Généreux, Gennaro Giustino, Bernhard Witzenbichler, et al.
Transfusion|February 11, 2012
Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) studySara Richman, Adrian P Gee, David H McKenna, et al.
Circulation|October 13, 2021
Systems of Care for ST-Segment-Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAlice K Jacobs, Murtuza J Ali, Patricia J Best, et al.
Circulation. Cardiovascular Interventions|October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES StudyGiora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The Canadian Journal of Cardiology|January 29, 2026
Defining Population at Risk and Assessment of Patients with Presumed Coronary Microvascular and Vasomotor DysfunctionLaurie-Anne Boivin-Proulx, Erick Schampaert, Kevin Bainey, et al.
Circulation. Cardiovascular Interventions|December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting StentsAkiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
Pageof 58